Adam Levy
Directeur Général chez NEXGEL, INC.
Fortune : 635 488 $ au 31/05/2024
Provenance du réseau au premier degré de Adam Levy
Entité | Type d'entité | Industrie | |
---|---|---|---|
11
| Public Company | Chemicals: Specialty | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Adam Levy via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
ENVERIC BIOSCIENCES, INC. | Pharmaceuticals: Other | Chief Executive Officer President | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Celgene Global Health | Chief Executive Officer | ||
BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Investment Banks/Brokers | Analyst-Equity | |
METASTAT, INC. | Electrical Products | Chairman | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Trek Therapeutics PBC
Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Mali Health Organizing Project | Director/Board Member | ||
Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
University of California, Davis | College/University | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
PTC Corp. | Director/Board Member | ||
The Arthritis Foundation
The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Arthritis Foundation provides funds research, advocacy and support services for various kinds of arthritis and related diseases. It offers programs and services including aquatic programs, information about treatment breakthroughs, exercise tips for people with the disease and pain management information. Arthritis Foundation is located in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
Central New Jersey Council Boy Scouts of America
Central New Jersey Council Boy Scouts of America Miscellaneous Commercial ServicesCommercial Services Central New Jersey Council Boy Scouts of America provides programs, events and opportunities of a lifetime that serve to shape the lives of young men and women in Central and Northern New Jersey. The company was founded in 1995 and is headquartered in Monmouth Junction, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
International Castlemans Disease Organization | Director/Board Member | ||
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Nephila Advisors (UK) Ltd.
Nephila Advisors (UK) Ltd. Financial ConglomeratesFinance Nephila Advisors (UK) Ltd. provides investor relations and business development services to Nephila Capital Ltd. The company was founded on December 12, 2013 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Relief Mental Health LLC | Director/Board Member | ||
Third Eye Health, Inc.
Third Eye Health, Inc. Medical/Nursing ServicesHealth Services Third Eye Health, Inc. is a national healthcare company. It provides remote and bedside medical care to senior care organizations. The company was founded by Daniel Herbstman, Lucas Baran, and Jamison Feramisco in 2014 and is headquartered in Chicago, IL. | Medical/Nursing Services | Director/Board Member | |
Key Autism Services, Inc.
Key Autism Services, Inc. Medical/Nursing ServicesHealth Services Key Autism Services, Inc. provides mental health care services. | Medical/Nursing Services | Director/Board Member | |
Vitae Health Systems | Hospital/Nursing Management | Chief Executive Officer | |
Cane Investment Partners LLC
Cane Investment Partners LLC Investment ManagersFinance Cane Investment Partners LLC (Cane Investment) is a private equity and venture capital firm founded in 2014. The firm is headquartered in Skokie, Illinois. | Investment Managers | Corporate Officer/Principal | |
Susquehanna University | College/University | Undergraduate Degree | |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US. | Pharmaceuticals: Major | Director of Finance/CFO | |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Nephila Capital Ltd. (Tennessee)
Nephila Capital Ltd. (Tennessee) Financial ConglomeratesFinance Part of Markel Group, Inc., Nephila Capital Ltd. is a company based in Nashville, TN that provides reinsurance and investment management services. | Financial Conglomerates | Corporate Officer/Principal | |
Vanderbilt University | College/University | Undergraduate Degree | |
Nephila 2357 Ltd.
Nephila 2357 Ltd. Specialty InsuranceFinance Nephila 2357 Ltd. is an insurance underwriting and reinsurance services provider. The private company is based in London, UK. The British company was founded in 2012. | Specialty Insurance | Director/Board Member | |
ImmuneRegen BioSciences, Inc.
ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneRegen BioSciences, Inc. researches and develops immunomodulation to improve pulmonary function and stimulating the human immune system. The company is headquartered in Scottsdale, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
ROYALTY PHARMA PLC | Pharmaceuticals: Major | Chief Investment Officer | |
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 46 |
Royaume-Uni | 4 |
Israël | 3 |
Sectorielle
Health Technology | 24 |
Consumer Services | 7 |
Finance | 6 |
Health Services | 5 |
Commercial Services | 5 |
Opérationnelle
Director/Board Member | 60 |
Corporate Officer/Principal | 22 |
Chairman | 20 |
Independent Dir/Board Member | 18 |
Chief Executive Officer | 15 |
Relations les plus connectées
Insiders | |
---|---|
Jerome Zeldis | 38 |
Dave Stefansky | 21 |
David Ian Johnson | 15 |
Miranda Toledano | 13 |
Nachum Stein | 11 |
Avani Kanubaddi | 10 |
Scott Henry | 9 |
Yaakov Spinrad | 7 |
Adam Drapczuk | 6 |
Steven Glassman | 5 |
Gregory J. Robb | 1 |